Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen is a paper indexed in PICO Portal from OpenAlex.
How many citations does Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen have?
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen has 66 citations in the OpenAlex counts PICO Portal stores.
When was Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen published?
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen has 2021 year in the PICO Portal index.
What is the open-access status of Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen?
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen has hybrid oa status in the PICO Portal index.
What is the DOI of Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen?
The DOI for Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen is on the source record.
What is the PMID of Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen?
The PMID for Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen is on the source record.
What is the OpenAlex record for Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen?
The OpenAlex for Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen is on the source record.